Kinetics Of BCR-ABL Transcripts In Patients with Chronic Phase CML (CML-CP) Treated With Imatinib Mesylate (Im): A Predictor Of Response And Progression Free Survival (PFS)

Citation:
Mahmoud, H. K., Y. H. El Nahas, M. A. Samra, R. M. Abdelfattah, M. A. ElEmary, and W. H. El-Metnawy, "Kinetics Of BCR-ABL Transcripts In Patients with Chronic Phase CML (CML-CP) Treated With Imatinib Mesylate (Im): A Predictor Of Response And Progression Free Survival (PFS)", Haematologica, vol. 94, issue S2, pp. 573: Abst 1473., 2009.
Tourism